nisoldipine has been researched along with Chronic Kidney Failure in 7 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)." | 6.65 | [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984) |
| "Patients with a stable progression of chronic renal failure with a creatinine clearance of 15-45 mL/min were randomly assigned to two groups of antihypertensive therapy: 1--nisoldipine as the only antihypertensive agent and 2--antihypertensive drugs without calcium channel blockers and a placebo tablet instead of nisoldipine." | 2.67 | Calcium channel blocker nisoldipine in chronic renal failure. ( Blau, A; Eliahou, HE; Herzog, D; Sachs, D; Shechter, P, 1990) |
| "In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)." | 2.65 | [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wambach, G | 1 |
| Breuer, G | 1 |
| Kaufmann, W | 1 |
| Blau, A | 1 |
| Herzog, D | 4 |
| Shechter, P | 3 |
| Sachs, D | 1 |
| Eliahou, HE | 4 |
| Shimamatsu, K | 1 |
| van Harten, J | 1 |
| Burggraaf, J | 1 |
| van Brummelen, P | 1 |
| Breimer, DD | 1 |
| Cohen, D | 3 |
| Serban, I | 2 |
| Kapuler, S | 3 |
| Schiby, G | 1 |
| Gavendo, S | 2 |
| Ben-David, A | 2 |
| Kogan, N | 2 |
| Hellberg, B | 2 |
4 trials available for nisoldipine and Chronic Kidney Failure
| Article | Year |
|---|---|
[Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
Topics: Adult; Aged; Aldosterone; Calcium Channel Blockers; Electrolytes; Female; Heart Rate; Humans; Hydroc | 1984 |
Calcium channel blocker nisoldipine in chronic renal failure.
Topics: Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Follow-Up Studies; Human | 1990 |
The calcium channel blocker nisoldipine delays progression of chronic renal failure in humans (preliminary communication).
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Dietary Proteins; Follow-Up Studies; Humans; Hypert | 1988 |
Effect of the calcium channel blocker nisoldipine on the progression of chronic renal failure in man.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Dietary Proteins; Energy Intake; Female; Huma | 1988 |
3 other studies available for nisoldipine and Chronic Kidney Failure
| Article | Year |
|---|---|
Diastolic blood pressure and progression of chronic renal failure.
Topics: Diastole; Glomerulonephritis; Humans; Hypertension; Kidney Failure, Chronic; Myocardial Contraction; | 1990 |
Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.
Topics: Administration, Oral; Adult; Blood Pressure; Calcium Channel Blockers; Drug Administration Schedule; | 1989 |
The control of hypertension and its effect on renal function in rat remnant kidney.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Creatinine; Dietary Proteins; Dihydralazine; Fema | 1988 |